Jessica Longo Discusses Support for Cardiometabolic Patients

Novo Nordisk executive dives into supporting cardiometabolic patients within her current role.

In an interview with Pharma Commerce Editor, Nicholas Saraceno, Jessica Longo, director of patient support, cardiometabolic, and PAP, describes her role in supporting cardiometabolic patients.

Related Content:

Patient Assistance & Access ProgramsVideosPatient Support
Novo Nordisk, Valo Health Grow Partnership Centered Around Cardiometabolic Disease Therapies
FDA Accepts Review of New GSK Prefilled Syringe Presentation
The Evolution of Pharmaceutical Sample Distribution: From Push to Pull